Biopharma Drug Development: How is the Evolving Landscape Affecting Companies Along the Continuum?
The global contract research organization (CRO) services market is growing and projected to reach $56.34 Billion by 2023. However, there are several significant changes impacting the industry – a declining number of pharmaceutical customers, advances in new technologies such as immuno-oncology and industry consolidation.
Indiana is home to nearly 50 CRO companies and their 7,000 employees who support the growing needs of pharmaceutical and biotech companies. Performing drug development from discovery to delivery, these companies are the sparkplug to Indiana’s booming life sciences industry.
In this session, we’ll hear firsthand from CRO leaders how their sector is evolving and how our local companies are adapting to these changes:
- Diana Caldwell, Pearl Pathways
- Vic Vinci, Catalent
- John (JJ) Spegele, Covance Central Labs
- Moderator: Terri Pascarelli, AIT Bioscience
- April 17, 2018
- Time:8:00 am - 10:00 am
- Butler University Fairview House Community Room
- 4550 Sunset Ave IN
Indianapolis, IN 46208 United States + Google Map